Combined-Modality Therapy for Unresectable, Stage III Non-Small-Cell Lung Cancer--Caveat Emptor or Caveat Venditor?
Open Access
- 4 September 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 88 (17) , 1175-1177
- https://doi.org/10.1093/jnci/88.17.1175
Abstract
David H. Johnson; Combined-Modality Therapy for Unresectable, Stage III Non-Small-Cell Lung Cancer—Caveat Emptor or Caveat Venditor?, JNCI: Journal of the NatiKeywords
This publication has 0 references indexed in Scilit: